| dc.contributor.author | Kockaya, G. | |
| dc.contributor.author | Cavus, F. | |
| dc.contributor.author | Ozin, B. | |
| dc.contributor.author | Yilmaz, K. C. | |
| dc.contributor.author | Ciftci, O. | |
| dc.contributor.author | Ergin, Oguzhan G. | |
| dc.contributor.author | Saylan, M. | |
| dc.date.accessioned | 2020-06-21T13:06:30Z | |
| dc.date.available | 2020-06-21T13:06:30Z | |
| dc.date.issued | 2018 | |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issn | 1524-4733 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jval.2018.09.617 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/11373 | |
| dc.description | WOS: 000459985600535 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.relation.isversionof | 10.1016/j.jval.2018.09.617 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Effect of Time in Therapeutic Range on Cost and Clinical Outcomes of Atrial Fibrilation Patients : A Cost-Consequences Analysis of Rivaroxaban Vs Warfarin For Turkey | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 21 | en_US |
| dc.identifier.startpage | S104 | en_US |
| dc.identifier.endpage | S104 | en_US |
| dc.relation.journal | Value in Health | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
